J
José Luis Zamorano
Researcher at Carlos III Health Institute
Publications - 740
Citations - 154643
José Luis Zamorano is an academic researcher from Carlos III Health Institute. The author has contributed to research in topics: Heart failure & Myocardial infarction. The author has an hindex of 105, co-authored 695 publications receiving 133396 citations. Previous affiliations of José Luis Zamorano include Hospital Clínico San Carlos & Universidad Francisco de Vitoria.
Papers
More filters
Journal ArticleDOI
Updated Clinical Practice Guidelines on Heart Failure: An International Alignment
Elliott M. Antman,Jeroen J. Bax,Richard A. Chazal,Mark A. Creager,Gerasimos Filippatos,Jonathan L. Halperin,Steven R. Houser,JoAnn Lindenfeld,Fausto J. Pinto,Panos Vardas,Mary Norine Walsh,Kim A. Williams,José Luis Zamorano +12 more
TL;DR: The introduction of an angiotensin receptor-neprilysin inhibitor (ARNI), valsartan/sacubitril, and a sinoatrial node modulator, ivabradine, when applied judiciously, complement established pharmacological and device-based therapies, representing milestones in the evolution of care for patients with heart failure.
Journal ArticleDOI
Calcified right ventricular thrombus and antiphospholipid syndrome
Jose Alberto de Agustin,Iván J. Núñez-Gil,Borja Ruiz-Mateos,María del Carmen Manzano,David Vivas,Leopoldo Pérez de Isla,José Luis Zamorano,Carlos Macaya +7 more
TL;DR: A case about a 30-year-old woman, admitted with a 6-month history of arthralgia, fatigue, and intermittent fever, and the presence of a large and calcified mass in the right ventricular outflow tract attached to the subvalvular tricuspid apparatus is described.
Journal ArticleDOI
Hipertrofia ventricular izquierda por electrocardiograma o ecocardiograma y complicaciones cardiovasculares en hipertensos tratados de la Comunidad Autónoma de Madrid. Estudio MAVI-HTA*
TL;DR: Determinados pacientes hipertensos podrian beneficiarse del ecocardiograma en the valoracion del riesgo cardiovascular, y esta se asocio a una prevalencia of ECV tres veces superior.
Journal ArticleDOI
Effects of Ivabradine on Heart Rate and Hemodynamic Parameters in a Swine Model of Cardiogenic Shock.
Marina Pascual Izco,Borja Castejón,María José G.M. Piedras,José Luis Zamorano,Marcelo Sanmartín,Carlos Zaragoza +5 more
TL;DR: Preliminary data indicate that ivabradine may offer a benefit in situations of severe tachycardia and shock, probably as a result of lower oxygen consumption and oxidative stress, although the hemodynamic effects of the drug in this context are unknown.
Journal ArticleDOI
Nuclear magnetic resonance spectroscopy of excised human hearts.
François Brunotte,B. Peiffert,Jean Marie Escanyé,G. Pinelli,José Luis Zamorano,Paul Walker,Jacques Robert,Villemot Jp +7 more
TL;DR: The results suggest that theosphocreatine concentration is lower in ischaemic heart disease than in dilated cardiomyopathy and that the phosphodiester peak is probably not useful in distinguishing between these two types of heart disease.